[AQST] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[AQST] Aquestive Therapeutics, Inc.
Announcement Date
06-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 64.87%
YoY- 83.77%
Quarter Report
AQST's Result
AQST's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 20,099 12,053 13,206 13,002 13,241 11,134 10,682 52.46%
PBT -2,745 -12,828 -8,010 -2,175 -5,508 8,068 -12,352 -63.34%
Tax 0 164 101 -140 284 -11,238 5,797 -
NP -2,745 -12,828 -8,111 -2,035 -5,792 19,306 -18,149 -71.64%
Tax Rate - - - - - 139.29% - -
Total Cost 22,844 24,881 21,317 15,037 19,033 -8,172 28,831 -14.38%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -13.66 -106.43 -61.42 -15.65 -43.74 173.40 -169.90 -81.40%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.03 -0.17 -0.12 -0.03 -0.10 0.35 -0.33 -79.81%
EPS Diluted -0.03 -0.17 -0.12 -0.03 -0.10 0.26 -0.33 -79.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.